Eledon Pharmaceuticals, Inc. SEC filings ELDN

Eledon Pharmaceuticals, Inc. has 614 filings in SEC EDGAR's recent list, going back to Jun 18, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.

Eledon Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 22, 2026 Jun 18, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
8-K Current report
Results of operations
Mar 19, 2026 Mar 19, 2026
8-K Current report
Unregistered share sale
Jan 2, 2026 Dec 30, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
8-K Current report
Material agreement
Nov 13, 2025 Nov 12, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 7, 2025 Nov 6, 2025
8-K Current report
Results of operations, Restatement
Aug 14, 2025 Aug 11, 2025
8-K Current report
Regulation FD disclosure
Aug 6, 2025 Aug 6, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 12, 2025 Jun 10, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
8-K/A Amended current report
Auditor change
Apr 14, 2025 Apr 1, 2025
8-K Current report
Auditor change
Apr 7, 2025 Apr 1, 2025
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
8-K Current report
Officer or director change
Dec 20, 2024 Dec 16, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Oct 30, 2024 Oct 29, 2024
8-K Current report
Regulation FD disclosure
Oct 29, 2024 Oct 29, 2024
8-K Current report
Unregistered share sale
Oct 1, 2024 Sep 30, 2024
8-K Current report
Material agreement
Sep 20, 2024 Sep 20, 2024
8-K Current report
Results of operations, Restatement
Aug 14, 2024 Aug 13, 2024
8-K Current report
Auditor change
Jul 12, 2024 Jul 10, 2024
8-K Current report
Unregistered share sale
Jul 10, 2024 Jul 8, 2024
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jul 10, 2024 Jul 10, 2024
8-K Current report
Results of operations
May 13, 2024 May 9, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
May 7, 2024 May 6, 2024
8-K Current report
Results of operations
Mar 28, 2024 Mar 28, 2024
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Regulation FD disclosure
Nov 2, 2023 Nov 2, 2023
8-K Current report
Officer or director change
Oct 2, 2023 Sep 29, 2023
8-K Current report
Officer or director change
Sep 21, 2023 Sep 20, 2023
8-K Current report
Officer or director change
Sep 13, 2023 Sep 11, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 22, 2023 Jun 21, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
May 1, 2023 Apr 26, 2023
8-K Current report
Results of operations
Mar 30, 2023 Mar 30, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Shareholder vote results
Jun 23, 2022 Jun 22, 2022
8-K Current report
Regulation FD disclosure, Other events
May 31, 2022 May 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
8-K Current report
Results of operations
Mar 24, 2022 Mar 24, 2022
8-K Current report
Unregistered share sale
Jan 13, 2022 Jan 11, 2022
8-K Current report
Results of operations
Nov 12, 2021 Nov 12, 2021
8-K Current report
Results of operations
Aug 12, 2021 Aug 12, 2021
8-K Current report
Officer or director change
Aug 2, 2021 Jul 31, 2021
8-K Current report
Officer or director change
Jul 2, 2021 Jul 1, 2021
8-K Current report
Shareholder vote results
Jun 16, 2021 Jun 15, 2021
8-K Current report
Results of operations
May 13, 2021 May 13, 2021
8-K Current report
Other events
Apr 27, 2021 Apr 26, 2021
8-K Current report
Officer or director change
Mar 15, 2021 Mar 15, 2021
8-K Current report
Unregistered share sale
Jan 7, 2021 Dec 31, 2020
8-K Current report
Bylaw or fiscal year change, Other events
Jan 5, 2021 Jan 4, 2021
8-K Current report
Shareholder vote results
Dec 22, 2020 Dec 18, 2020
8-K Current report
Bylaw or fiscal year change
Dec 10, 2020 Dec 8, 2020
8-K Current report
Bylaw or fiscal year change
Nov 20, 2020 Nov 20, 2020
8-K/A Amended current report Nov 20, 2020 Sep 9, 2020
8-K Current report
Bylaw or fiscal year change
Oct 6, 2020 Oct 5, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Sep 15, 2020 Sep 9, 2020
8-K Current report
Officer or director change
Sep 4, 2020 Sep 3, 2020
8-K Current report
Exit or restructuring costs, Officer or director change
Jun 17, 2020 Jun 11, 2020
8-K Current report
Results of operations
May 15, 2020 May 15, 2020
8-K Current report
Shareholder vote results
May 13, 2020 May 12, 2020
8-K Current report
Listing notice
Apr 23, 2020 Apr 21, 2020
8-K Current report
Results of operations
Mar 17, 2020 Mar 17, 2020
8-K/A Amended current report
Unregistered share sale, Bylaw or fiscal year change
Feb 20, 2020 Feb 13, 2020
8-K Current report
Unregistered share sale, Bylaw or fiscal year change
Feb 19, 2020 Feb 13, 2020
8-K Current report
Listing notice
Feb 7, 2020 Feb 6, 2020
8-K Current report
Material agreement, Unregistered share sale
Jan 16, 2020 Jan 10, 2020
8-K Current report
Results of operations
Nov 13, 2019 Nov 13, 2019
8-K Current report
Results of operations
Aug 13, 2019 Aug 13, 2019
8-K Current report
Listing notice
Aug 9, 2019 Aug 8, 2019
8-K Current report
Auditor change, Officer or director change
Jul 12, 2019 Jul 11, 2019
8-K Current report
Results of operations
May 14, 2019 May 14, 2019
8-K Current report
Material agreement, Unregistered share sale, Other events
May 2, 2019 Apr 30, 2019
8-K Current report
Other events
Apr 22, 2019 Apr 22, 2019
8-K Current report
Results of operations
Mar 28, 2019 Mar 28, 2019
8-K Current report
Regulation FD disclosure
Jan 8, 2019 Jan 7, 2019
8-K Current report
Results of operations
Nov 13, 2018 Nov 13, 2018
8-K Current report
Results of operations
Aug 7, 2018 Aug 7, 2018
8-K Current report
Shareholder vote results
Jun 14, 2018 Jun 13, 2018
8-K Current report
Results of operations
May 11, 2018 May 11, 2018
8-K Current report
Results of operations
Apr 2, 2018 Mar 30, 2018
8-K Current report
Other events
Mar 12, 2018 Mar 9, 2018
8-K Current report
Results of operations
Nov 29, 2017 Nov 29, 2017
8-K Current report
Results of operations
Nov 8, 2017 Nov 8, 2017
8-K Current report
Officer or director change
Nov 6, 2017 Nov 6, 2017
8-K Current report
Shareholder vote results
Sep 29, 2017 Sep 28, 2017
8-K Current report
Material agreement
Aug 22, 2017 Aug 21, 2017
8-K Current report
Results of operations
Aug 10, 2017 Aug 9, 2017
8-K/A Amended current report Jul 25, 2017 May 9, 2017
8-K Current report
Officer or director change
Jul 10, 2017 Jul 10, 2017
8-K Current report
Officer or director change
May 31, 2017 May 24, 2017
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
May 15, 2017 May 9, 2017
8-K Current report
Other events
Apr 28, 2017 Apr 11, 2017
8-K Current report
Listing notice
Mar 9, 2017 Mar 8, 2017
8-K Current report
Material agreement, Unregistered share sale
Feb 3, 2017 Jan 31, 2017
8-K Current report
Material agreement, Unregistered share sale, Other events
Dec 22, 2016 Dec 21, 2016
8-K Current report
Officer or director change
Oct 12, 2016 Oct 10, 2016
8-K Current report
Regulation FD disclosure
Aug 22, 2016 Aug 22, 2016
8-K Current report
Exit or restructuring costs, Officer or director change
Aug 3, 2016 Jul 28, 2016
8-K Current report
Results of operations, Other events
Jul 26, 2016 Jul 26, 2016
8-K Current report
Shareholder vote results
Jun 16, 2016 Jun 15, 2016
8-K Current report
Officer or director change
May 31, 2016 May 27, 2016
8-K Current report
Regulation FD disclosure, Other events
Jan 7, 2016 Jan 7, 2016
8-K Current report
Shareholder vote results
Jun 18, 2015 Jun 17, 2015
8-K Current report
Material agreement
Jun 12, 2015 Jun 9, 2015
8-K Current report
Officer or director change
Apr 15, 2015 Apr 9, 2015
8-K Current report
Material agreement
Mar 19, 2015 Mar 13, 2015
8-K Current report
Results of operations
Mar 18, 2015 Mar 12, 2015
8-K Current report
Material agreement
Mar 5, 2015 Feb 27, 2015
8-K Current report
Material agreement, Other events
Jan 15, 2015 Jan 9, 2015
8-K Current report
Officer or director change
Jan 9, 2015 Jan 8, 2015
8-K Current report
Results of operations
Nov 10, 2014 Nov 10, 2014
8-K Current report
Officer or director change
Oct 17, 2014 Oct 15, 2014
8-K Current report
Other events
Oct 9, 2014 Oct 9, 2014
8-K Current report
Bylaw or fiscal year change
Sep 26, 2014 Sep 22, 2014

Showing 120 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ELDN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1404281
Former names
Eledon Pharmaceuticals, Inc. (until Oct 30, 2026); Novus Therapeutics, Inc. (until Dec 22, 2020); Tokai Pharmaceuticals Inc (until May 4, 2017)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.